Workstream 1: Understanding Cancer Risk
Identifying cancer risk factors and developing better tools for prevention and early detection.


Breast cancer genomics, diagnostics, liquid biopsies, and Al-driven translational oncology.
Head of Translational Oncogenomics, Division of Oncology, Medical Faculty; Co-PI of SCAN-B and Head of SCAN-B Translational Research. Founder and former CEO of SAGA Diagnostics AB (acquired by Roche).
His research focuses on cancer genomics, precision oncology, biomarkers, and translating molecular discoveries into personalized cancer diagnostics and treatment.
Related Workstreams
Identifying cancer risk factors and developing better tools for prevention and early detection.
